Evidence map›Paper›PMID 41882184›Full record

ArticleScientific reports2026

Highly efficient and sustainable removal of cyclophosphamide with activated carbon produced from peanut shells: chemical adsorption mechanism.

Çiğdem Aşçıoğlu, İbrahim Bulduk, Ayşegül Türk Baydır

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Çiğdem AşçıoğluDepartment of Food Engineering, Faculty of Engineering, Afyon Kocatepe University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0001-6407-8104
İbrahim BuldukDepartment of Chemical Engineering, Faculty of Engineering, Afyon Kocatepe University, Afyonkarahisar, Turkey.ORCID http://orcid.org/0000-0001-6172-7738
Ayşegül Türk BaydırDepartment of Chemical Engineering, Faculty of Engineering, Afyon Kocatepe University, Afyonkarahisar, Turkey. aturkbaydir@aku.edu.tr.ORCID http://orcid.org/0000-0003-3014-3152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the feasibility of activated carbon produced from peanut shells via chemical activation for the removal of cyclophosphamide (CP) from aqueous solutions. CP, a cytotoxic antineoplastic drug, is frequently detected in hospital wastewater at concentrations ranging from ng/L to µg/L. However, it cannot be effectively removed by conventional biological and physical–chemical treatment technologies. Peanut shells were converted into activated carbon by KOH activation. The resulting adsorbent exhibited a surface area of 912 m2/g and a total pore volume of 0.58 cm3/g by BET analysis. SEM images revealed an irregular and highly macro- and mesogogenic morphology. In batch adsorption experiments, CP removal exceeding 98.5% was achieved with an adsorbent dose of 0.4 g/L, a neutral pH, an initial concentration of ≤ 40 mg/L, and a contact time of 60 min. Equilibrium data showed excellent fit to the Langmuir isotherm model (R2 = 0.9999), while kinetic data showed excellent fit to the pseudo-second-order model (R2 = 0.9998). Thermodynamic analyses revealed that the process was endothermic (ΔH° =  + 59.26 kJ/mol) and spontaneous (ΔG° < 0). Consequently, peanut shell-derived activated carbon has proven to be a cost-effective, environmentally friendly, and highly efficient adsorbent and a strong alternative for the treatment of pharmaceutical wastewater containing CP.

Indexed as

AdsorptionCyclophosphamide removalPeanut shell activated carbonPharmaceutical wastewaterSustainable adsorbent

Identifiers

PMID41882184
PMCPMC13184096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.